Debanjana Chatterjee
Stock Analyst
(n/a)
# 4,626
Out of 4,654 analysts
3
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Initiates: Buy | $35 | $9.80 | +257.14% | 1 | Sep 27, 2024 | |
| PHVS Pharvaris | Initiates: Buy | $46 | $20.55 | +123.84% | 1 | Sep 19, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Buy | $41 | $15.12 | +171.16% | 1 | Sep 17, 2024 |
KalVista Pharmaceuticals
Sep 27, 2024
Initiates: Buy
Price Target: $35
Current: $9.80
Upside: +257.14%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $20.55
Upside: +123.84%
Intellia Therapeutics
Sep 17, 2024
Initiates: Buy
Price Target: $41
Current: $15.12
Upside: +171.16%